d517a thailand biotech guide 2006-2007
TRANSCRIPT
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
1/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 78
hai land has long real ized the
importance of biotechnology and the
tremendous benefits of having a
strong biotechnology sector. Given its position
as a world leader in tropical medicine, health
services, agriculture and food production,
Thailand recognizes that the biotechnology
industry will help strengthen the countrys
capabilities in these areas and contribute to
future growth and competitiveness.
Since the early 80s, Thailand had already taken
steps to encourage and nurture a fledgling
biotechnology industry. Early initiatives such as
the establishment of the National Center for
Genetic Engineering and Biotechnology (BIOTEC)
provided the necessary impetus and laid a strong
foundation for biotechnology human resource
development and R&D activities. Setting up of
the National Science and Technology Development
Agency (NSTDA) in 1991 reaffi rmed the
belief in building S&T infrastructure to build
competitiveness and upgrading S&T capacity. In
addition, with the approval of the National
Biotechnology Policy Framework by the Thai
Cabinet in 2004, the industry can now work
towards a clear set of goals, namely in using
biotechnology to promote the development of
new bio-businesses, enhance the competitiveness
of the Thai food and agriculture industries, raise
the level of medical healthcare services in the
kingdom, conserve the environment and
produce clean energy, create a self-sufficient
economy and develop qualified human resource.
As a result, the local biotechnology industry has
grown. Thailand has already attracted a number
of multinational corporations to base their R&D
activities here. It is also home to a rapidly
growing international medical tourism industry
whose world-class hospitals and medical
professionals are bringing in more than a
million visitors a year from around the world.
Biotechnology is todays frontier of Science and
BIOTEC, which has since become a part of NSTDA,
has used various NSTDAs instruments in playing
a key role of creating a conducive research
environment, a critical pool of talents and
effective infrastructure and tools that will enable
biotechnology to benefit the country and the
well being of the people. Furthermore, we are
continually strengthening the industry by bringing
together multiple disciplines, synergizing with
key partners and promoting both local and
international collaborations.
Market-driven initiatives such as the Thailand
Biotech Guide which showcases the local industry
and provides access to important market
information, is evident of an industry that is
moving to the next level of development. I hope
the readers will gain insights into Thailands
biotechnology industry and come to appreciate
the many prospects and opportunities that
are abound here.
Sakarindr Bhumiratana, Ph.D.
President
National Science and Technology
Development Agency (NSTDA)
T
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
2/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 9
ver the years, with sustained
commitment from the government
and concerted efforts from the
relevant agencies, Thailand has focused on
developing a biotechnology base that will
bring its agriculture-dominant economy to
the next level.
Agencies such as BIOTEC, NSTDA and the
BOI have worked closely together to promote
the long-term growth and development of
Thailand's biotechnology sector. Through their
efforts, the creation of biotechnology
incentives, funding and other forms of
support were undertaken specifically to
provide an environment conducive for growth
in this important sector. And now we are
starting to see the emergence of a promising
industry that currently boasts a small but
increasing number of biotechnology companies.
The creation of the Thailand Biotech Guide
by an industry-driven consortium is another
indication that the sector has reached an
important milestone. The demand for key
industry information has now reached
critical mass.
I am confident that this new publication,
the Thailand Biotech Guide will become an
invaluable resource for the local biotechnology
industry, as well as foreign companies and
investors. My best wishes to the publishers,
and I look forward to seeing this publication
grow as Thailand's biotechnology industry
powers forward into the future.
Satit Chanjavanakul
Secretary General Board of Investment
O
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
3/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 11
ince adopting the National Biotechnology Policy Framework in 2004, Thailand has made significant
progress in developing the necessary infrastructure and nurturing specific sectors in its growing biotech
industry. There has been increasing interest in the local biotech industry especially from potential foreign
investors that are keen to learn about the countrys focus and strengths in the biotech field.
The Thailand Biotech Guide is created to provide comprehensive coverage of the operational details related to the
establishment of a local biotech operation and enterprise. Our aim is to develop a publication that presents
relevant and practical information to all potential stakeholders and contributors to the Thailand biotech scene. We
envisage that the guide will become an important source of reference for the local biotech industry and will help
promote Thailands biotech sector to the world.
We will like to take this opportunity to thank our advertisers for their support, without which this guide will not
have been possible. We hope that you will find this guide useful and we look forward to your comments andfeedback to help us improve th is publ icat ion further. Please feel free to drop us an emai l at
Co-Editors
S
Derrick Tan, Ph.D.
Managing Consultant1st Phase Operations
Marvin Ng, MBA
Business Development ConsultantGreener Grass Communications
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
4/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 15
Thailand Land ofInvestment Opportunities
Thailand is a key economy in South East Asia, with an
estimated population of 66 million and a gross domestic
product (GDP) of over 7,100 billion baht or US$ 186
billion in 2005. Having weathered the Asian financial crisis
in 1997, Thailand has undergone a remarkable economic
transformation which propelled the economy from about
minus 10% growth to almost 7% growth in 2003.
Although economic performance has slowed down in 2004
and 2005 due in part to rising oil prices, the 2004 tsunami
and the outbreak of avian flu, the economy has remained
robust, with 2005 GDP growing at 4.7%.
In 2005, Thailand was rated the third most attractive FDI
destination in Asia (behind India and China) by a UNCTAD
survey. The kingdom is host to a growing number of
MNCs operating out of Asia for a few reasons. Firstly,
Thailand has a sizeable and growing economy with a
substantial domestic market that represents significant
opportunities for companies interested in tapping into local
demands. Secondly, Thailand is committed to creating a
business-friendly and low-cost operating environment thatis conducive to foreign companies. Other key factors
contributing to Thailand's attractiveness as a preferred
investment destination include its young and educated
workforce, its geographical location and its excellent logistic
infrastructure.
Thailand has already established itself as a global base for
a number of industries such as the automotive, electronic
and education sectors. For instance, world-class automotive
players such as Honda and Toyota both have significant
manufacturing and R&D operations in Thailand that cater to
the global market. Similarly, Thailand is also the world's
largest hard disk drive producer with most of the leading
hard disk drive players such as Seagate, Western Digital
and Fujitsu, tapping on the unique strengths of Thailand
and investing in major manufacturing and developmentoperations in the country. In the same way, biotechnology
companies are discovering Thailand as a promising
investment destination. The country, which is a hot spot in
bio-diversity, has a large domestic and regional market, as
well as a ready supply of competent scientific workers and
scientists. Furthermore, it has developed dedicated
infrastructure and has put in place, attractive schemes and
incentives to support the industry.
The Thailand BioIndustry An Up andComing Sector
Thailand regards biotechnology as an important industry
sector that needs to be developed in order to strengthen its
global competitiveness. The Thai government has
recognized the tremendous value of biotechnology in
enhancing economic productivity, especially in the agriculture
and food sectors which are mainstays of the Thai economy.In particular, there is strong interest to use biotechnology
for a variety of act ivities including processing food,
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
5/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 716
increasing value-add of products, improving the genetic
stock of plants and livestock, developing diagnostics,
enhancing aquaculture and developing biological control.
As early as the 1980s, initiatives such as the creation of the
National Center for Genetic Engineering and Biotechnology(BIOTEC) were launched to promote the development of
the local industry. More recently, the Thai government
developed the National Biotechnology Policy Framework
(2004-2009), which aims to bring about US$125 million in
R&D investments and the creation of more than 100 new
biotech-related companies in the next few years. To meet
these objectives, the government has provided significant
resources to create an environment conducive for the growth
of biotechnology industry including setting up a dedicatedBioPark for R&D, creating training and business activities
as well as establishing incentives and assistance programmes
aimed at promoting the industry.
Key clusters within the bioindustry in Thailand include the
Agri-biotech sector, the Medical sector and the Food sector.
Agri-Biotech Sector
Thailand is a major agriculture exporter, with more than a
third of its land being arable and about half of the country's
labour force involved in agriculture. In 2005, the country's
agriculture output contributes 8.7% to its GDP. Thus, the
Thai government has long realized that biotechnology,
applied to the country's agriculture base, can bring
tremendous benefits to the economy and people.
With a large industrial base, in-depth experience and expertise
in this area, Thailand possesses significant strengths inbiotechnology within the agricultural sector and is already
home to a number of international companies such as Bayer
Cropscience, Monsanto and Syngenta. The country is now
leveraging upon biotechnology advances to further develop
the field and grow the industry. For example, marker assisted
selective breeding has been used to develop disease resistant
crops such as rice. Similarly, recombinant DNA techniques
are used to produce more hardy transgenic plants including
tomato, papaya and pepper. Biotechnology is also finding itsway into other areas such disease (livestock and crops)
diagnostics and agricultural product traceability.
Within the same sector, biotechnology is playing anincreasingly important role in the production of biofuels and
materials from agricultural biomass. One specific example
is the government's active support for projects related to
the production of bioethanol from cassava, sugar cane and
other agricultural materials, in an effort to augment the
country's energy needs.
In the area of human resource development for the
agri-biotech sector, Thailand is not only focusing on its
own needs but also those of the region. It is establishing
itself as a regional hub for training and development. For
instance, the Asian Development Bank has sponsored
training initiatives that are based in Thailand which reach
out to participants from neighbouring countries. This aims
to strengthen the agriculture capaci ty and advanced
agricultural science and technology cooperation among
nations in the region.
Medical Sector
Thailand is poised to become the region's leading healthcare
hub with over a million medical tourists arriving each year
seeking treatments including cosmetic surgery, dental work,
hip and knee replacements and back surgery. Thai doctors
and other medical staff study abroad, speak international
languages and are among the best qualified in the region.
Many private hospitals have translators to facilitate
convenient communication with foreign visitors. The hospitalfacilities themselves offer spacious, luxurious accommodation
and in some ways seem more like five-star hotels, with in-house
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
6/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 17
restaurants and food courts, spa and fitness facilities. Tourists
from the United States, Europe and increasingly the Middle
East are attracted to Thailand specifically because of its
high-quality, attractively packaged and very affordable medical
treatments. Furthermore, Thai land also offers medical
treatments that are sometimes unavailable to these medicaltourists back in their home countries, for example stem
cell therapies. In 2005 alone, medical tourism brought in
more than half a billion dollars for the Thai economy.
With its superb medical healthcare infrastructure, well-trained
medical personnel and a growing research base, the sector
is poised to become a major clinical development center in
the region. Thailand has established a number of initiatives
to make this happen. For example, it has undertaken theThai Pharmacogenomics Project with the aim of creating a
comprehensive clinical database that will ultimately facilitate
new drug discovery efforts with leading pharmaceutical
companies and reduce healthcare costs.
Thailand is also at the forefront in the application of stem
cell technology. There are already organizations in the
country that offers commercial applications such as cord
blood banking and stem cell therapies.
Food Sector
Thai food industry is the most dynamic and diverse in the
world. The sector contributes significantly to the country's
growth and prosperity. More than 11.72% of the country's
total exports originate from the food sector, and the industry,
together with the agriculture sector, employs almost 20
million people in 2003. There are about 10,000 food-related
manufacturing operations in Thailand and 80% of the raw
materials that go into production are harvested locally. Given
the importance of the sector, it is not surprising that the
industry is continuously looking to improve itself. This
presents further opportunities for companies to improve upon
existing production or add value to existing products through
the use of technologies including biotechnology.
In general, the sector is moving towards higher
value-added, functional foods and nutraceuticals. It is alsodeveloping a more robust value chain that incorporates
higher standards, better safety and strong regulations. For
instance, Thailand's shrimp industry has managed to raise
its productivity and stay ahead of other food exporting
countries through the effective deployment of biotechnology.
The industry has benefited from initiatives such as the
Shrimp Genome Project and the Shrimp Traceability Project
which have helped to improve the shrimp breeding and
cultivation as well as raise the quality and safety standards
of the industry respectively.
More details on opportunities in Thailand biotechnology
industry can be found online at the BIOTEC website at
h t t p : / / w ww . b i o t e c . o r . t h / b i o t e c h n o l o g y - e n /
newsdetail.asp?id=1420.
The National BiotechnologyPolicy Framework ProvidingClear Directions
The National Biotechnology Policy Framework was formallyestablished in 2003 with the aim of developing a
competitive and self-sufficient Thai biotechnology industry.
restaurants and food courts, spa and fitness facilities. Tourists
from the United States, Europe and increasingly the Middle
East are attracted to Thailand specifically because of its
high-quality, attractively packaged and very affordable medical
treatments. Furthermore, Thai land also offers medical
treatments that are sometimes unavailable to these medicaltourists back in their home countries, for example stem
cell therapies. In 2005 alone, medical tourism brought in
more than half a billion dollars for the Thai economy.
With its superb medical healthcare infrastructure, well-trained
medical personnel and a growing research base, the sector
is poised to become a major clinical development center in
the region. Thailand has established a number of initiatives
to make this happen. For example, it has undertaken theThai Pharmacogenomics Project with the aim of creating a
comprehensive clinical database that will ultimately facilitate
new drug discovery efforts with leading pharmaceutical
companies and reduce healthcare costs.
Thailand is also at the forefront in the application of stem
cell technology. There are already organizations in the
country that offers commercial applications such as cord
blood banking and stem cell therapies.
Food Sector
Thai food industry is the most dynamic and diverse in the
world. The sector contributes significantly to the country's
growth and prosperity. More than 11.72% of the country's
total exports originate from the food sector, and the industry,
together with the agriculture sector, employs almost 20
million people in 2003. There are about 10,000 food-related
manufacturing operations in Thailand and 80% of the raw
materials that go into production are harvested locally. Given
the importance of the sector, it is not surprising that the
industry is continuously looking to improve itself. This
presents further opportunities for companies to improve upon
existing production or add value to existing products through
the use of technologies including biotechnology.
In general, the sector is moving towards higher
value-added, functional foods and nutraceuticals. It is alsodeveloping a more robust value chain that incorporates
higher standards, better safety and strong regulations. For
instance, Thailand's shrimp industry has managed to raise
its productivity and stay ahead of other food exporting
countries through the effective deployment of biotechnology.
The industry has benefited from initiatives such as the
Shrimp Genome Project and the Shrimp Traceability Project
which have helped to improve the shrimp breeding and
cultivation as well as raise the quality and safety standards
of the industry respectively.
More details on opportunities in Thailand biotechnology
industry can be found online at the BIOTEC website at
h t t p : / / w ww . b i o t e c . o r . t h / b i o t e c h n o l o g y - e n /
newsdetail.asp?id=1420.
The National BiotechnologyPolicy Framework ProvidingClear Directions
The National Biotechnology Policy Framework was formallyestablished in 2003 with the aim of developing a
competitive and self-sufficient Thai biotechnology industry.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
7/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 718
The framework provides direction over a period of 6 years
(2004-2009), with 6 specific goals for the development of
the industry as follows:
Emergence and Development of New Bio-Business
To encourage investment in R&D and establish biotechnology
companies which can tap on new opportunities in both
high value-added manufacturing (e.g. production of medical
diagnostic kits and supplementary food) and services
(e.g. molecular-level detection and analysis for medical care,
public health, agriculture and biosafety).
Biotechnology Promotes Thailand as Kitchen of
the World -
To use biotechnology to enhance Thailand's competitiveness
in the agriculture and food industries. The goal is to
increase the export value of the country's raw and
processed agricultural products.
Thailand Represents Healthy Community and
Healthcare Center of Asia -
To utilize biotechnology to improve the medical healthcare
of the nation and to establish Thailand as a lead hub for
healthcare services in Asia.
Utilization of Biotechnology to Conserve the
Environment and to Produce Clean Energy -
To apply biotechnology to the conservation and management
of the environment including energy production from waste,
improvement of soil quality, recycling as well as the inspection,
surveillance, treatment and rehabilitation of the environment.
Biotechnology as the Key Factor for Self-Sufficient
Economy -
To conserve and optimize the use of biological resources
that are important to, or specific in, various local communities.
The goal is to use biotechnology to extend the usefulness
of traditional know-how, expand the diversity and value of
local resources and resource-based products and to improve
the quality of these products.
Development of Qualified Human Resource -
To put in place infrastructure, resources and manpower
development programmes to create a quality workforce that
will support the growth of the industry.
More details on the NBPF can be found online at BIOTEC
website at http://www.biotec.or.th/biotechnology-en/policy.asp.
Strong Infrastructure to Support theDeveloping Industry
To support the development of the biotechnology industry,
Thailand has been putting in place critical infrastructure
necessary for industrial growth. The following sectiondescribes some of these in detail.
The Thailand Science Park
Located at the northern outskirt of Bangkok, the Thailand
Science Park represents the nation's first key infrastructure
development to promote its science and technology
research and development. The 80 acre park was completed
in 2002 and is currently managed by the team from theTechnology Management Center under the purview of the
National Science and Technology Development Agency
(NSTDA). The Park is currently undergoing Phase 2
expansion, while planning for Phase 3 development is
already in progress.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
8/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 19
The Park aims to be a fully integrated R&D hub to promote
the translation of innovative public R&D to the private sector,
as well as to provide training to advance the country's
critical mass of R&D professionals. To show its resolve to
make the Park the focus point of Thailand's science andtechnology activities, NSTDA houses its central administration
and various centers of excellence here. These include:
National Center for Genetic Engineering and
Biotechnology (BIOTEC),
National Electronics and Computer Technology
Center (NECTEC),
National Metal and Materials Technology Center
(MTEC), and
National Nanotechnology Center (NANOTEC)
In addition to these national centers, the Park provides
ready built research, pilot plant and business incubation
space for rental and long-term leasehold lands for companies
to construct their own research facilities. The Park management
also provides its tenants with one-stop services in the areas
of technology and technical, financial, human resource,
business and juristic support. Other benefits include access
to government research grants, soft loans, joint investment
by NSTDA and eligibility for Thailand Board of Investment'stax incentives (BOI Zone 3 incentives).
In the area of biotechnology, the abundance of state-of-the-
art research activities in agriculture, food and medical biotech
R&D have drawn an increasing number of companies to
set up shop within the Park. The Park currently houses
over 50 private companies, of which one third are active in
biotechnology. Some of the notable companies include
TV SD PSB (Thailand) Ltd., Betagro Group and the Shrimp
Biotechnology Business Unit. Over the years, there is also a
growing culture of scientific collaboration among BIOTEC,
the universities in the vicinity and private companies
located within the Park. BIOTEC also provides access to its
many core resources to private tenants at the Park, such as
the BioService Unit and DNA Technology Laboratory. An
ecosystem of biotech activities is taking shape at the
Thailand Science Park. More information about the Thailand
Science Park may be found at www.sciencepark.or.th.
With an aim of further developing the biotechnology sector,
the National Biotechnology Policy Committee recently
approved the expansion of the current biotech cluster
infrastructure at the Thailand Science Park into a full-fledged
BioPark. A sum of US$16.5 million has been allocated to
create an additional 40,000 sqm biotechnology lab space
by 2009, some of which will be BSL-3 level bio-containmentfacilities for use by private companies and public institutions.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
9/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 720
When completed, the BioPark will be Thailand's first biotech
hub to promote the advancement of life sciences research
and new bio-businesses.
The Industrial Estate Authority of Thailand
Established in 1972, the Industrial Estate Authority of
Thailand (IEAT) under the Ministry of Industry is tasked to
oversee the country's industrial development policies. In
addition, the state enterprise implements guidelines and
control measures to protect the country's environment against
harmful industrial pollution.
IEAT has developed more than 30 Industrial Estates across
the country, either on its own or jointly with privatedevelopers. These estates are generally equipped with many
of the essential infrastructure needed for a successful
industrial operation. As such, many biotech companies have
chosen to locate themselves within such estates to enjoy
the many privileges and incentives offered by IEAT. For
example, the agency provides a one-stop service to grant
licenses and permits necessary for operation initiation. It
also allows foreign investors to purchase the land they
occupy within certain estates. Additional information on the
various IEAT Industrial Estates and the privilege schemes
available may be found at www.ieat.go.th.
Other than these industrial estates, private developers alsooffer ready spaces or leasehold lands at various Industrial
Parks to potential investors. However, tenants in such
Industrial Parks are not eligible for IEAT incentives. In addition,
they do not have access to IEAT's business licenses and
permits facilitation services.
Investment Zones
Thailand's Board of Investment (BOI), through the
enactment of the Investment Promotion Act, divides the
country into several economic zones based on the regions
infrastructure availability and the local citizens income
levels. These zones serve as a guide for the agency to
direct different investment opportunities to the various
regions and to provide added incentives to promote
investment into the lesser developed provinces.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
10/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 21
Different tax and duty incentives and privileges are offered
by BOI at each of the zone. Details on these incentives may
be found at the BOI website at www.boi.go.th/english/about/
boi_privileges_by_location.asp.
Public R&D Focusing on Thailand'sStrengths
Much of the biotechnology R&D activities in Thailand are
concentrated in public research institutes and university
research centers. These organizations conduct a range of
research from publicly-funded upstream R&D to
commercially-driven collaborations with companies. With
Thailand's long history and experience in agriculture, aquaculture
and food production, strong biotechnology expertise can befound in areas including tropical disease, immunology, food
science and technology, fermentation and certain areas of
plant biotechnology. Furthermore, given the country's rich
biodiversity, Thailand has established large germbanks and
natural products libraries for use in agriculture research
and screening for bioactive compounds.
One of the leading biotechnology research institutes in
Thailand is the BIOTEC Central Research Unit, which wasestablished in 1996. It is the largest in-house research unit
under BIOTEC and NSTDA and conducts basic and applied
research as well as provides technical services to the industry.
Private R&D Activities CommerciallyDriven and Close to Market
Although biotechnology R&D activities are concentrated mostly
in public institutions, private sector R&D activities are alsogrowing. Increasingly, companies are working closely with
public R&D institutes and the universities to develop new
products and innovations. Some of the established local
firms in the agriculture and food industries collaborate with
the local inst itut ions in areas such as agricultural
biotechnology. One example is the Betagro Science Center,
initiated and funded by Betagro Group (one of Thailand's
largest agricultural and animal husbandry companies), which
is the nation's latest private advanced agro-based R&D
institute. The institute focuses on food safety - detecting
bacterial, viral or chemical contamination in products; this
includes the detection of emerging animal diseases, such
as the Avian flu.
In addition, Thailand is gradually being considered by global
firms as a base for R&D activities. It has attracted a number
of foreign investors that have established R&D activities and
research collaborations with local R&D organizations. Leading
international companies such as Shiseido and Novartis
currently work closely with NSTDA research centers. For
example, in 2005, Novartis established a three-year
partnership with BIOTEC aimed at developing new
medicines based on natural products found in Thailand.
Human Resource Development ACritical Component
Thailand recognizes that it must have a good pool of
scientists, doctors and other biotechnology professionals to
support the nation's developing biotechnology industry. At
present, there are a total of 24 public and private
universities that offer a program in biotechnology. Of these,
14 offer the program at post-graduate level i.e. Masters
or PhD.
In addition, there are joint research centers between BIOTEC
and leading local universities that provide research
programs which contributes to human resource
development. The Center of Excellence for Shrimp
Molecular Biology and Biotechnology at Mahidol University
and the Rice Gene Discovery Research Unit at Kasetsart
University are examples of such successful collaborations.
Besides the universities and joint research centers, a new
breed of problem-based learning institutes have also been
set up. These institutes focus on R&D training that
addresses the specific needs of the private sector. The
Chemical Engineering Practice School (ChEPS) and Food
Engineering Practice School (FEPS) which were developed
in collaboration with King Mongkut's University of Technology
Thonburi (KMUTT), are successful examples which have
produced graduates with skills and knowledge sought after
by the industry.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
11/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 722
The BIOTEC and NSTDA has committed to 244 national
and international scholarships/fellowships per year in order
to strengthen and develop capabilities to cope with technology
changes and future manpower demand.
In all, these programs help ensure a steady supply ofquality manpower that will meet the raising demands and
requirements of research institutes and new biotechnology
companies setting up in Thailand.
Thailand is also building up biotechnology research
capacities for the region. In 2001, Thailand, through BIOTEC,
initiated the Human Resource Development Program in
Biotechnology for Neighbouring Countries. The program
which is funded by the ASEAN Foundation and the NewZealand UNESCO Commission has trained a steady stream
of researchers from ASEAN countries and also provides a
networking platform for ASEAN researchers.
Support Schemes and GovernmentIncentives Promoting the Industry
There are a variety of assistance schemes and incentives
from government agencies to assist and attract biotechnologycompanies to set up presence in Thailand. The BOI is the
main government agency offering privileges and incentives
to investors. Companies that invest in biotechnology or
biotechnology-related businesses in Thailand may receive
tax or non-tax privileges if their projects receive approval
from the BOI. Tax privileges comprise of corporate income
tax exemption for up to 8 years, import duty reductions or
exemptions on machinery and raw materials. Non-tax
privileges include land ownership rights for foreign
investors, permission to bring in foreign experts and
technicians, and rapid processing of visa and work permit
applications. Companies with R&D activities can also apply
for 200% tax credit on R&D activities from the Thai
Revenue Department.
Biotechnology investors may qualify for financial support
packages from several other organizations. For example,
the Technology Management Center (TMC) offers grants
and soft loans for R&D or to upgrade manufacturing
processes for up to 75 percent of the project budget for
technology development projects (not exceeding US$750,000)
at a competitive interest rate. Various other programs are
available from the TMC including the Industrial Technology
Assistance Program (to provide financial support tocompanies seeking external experts from Thailand and
overseas) and the Support for Technology Acquisition and
Mastery Program (to facilitate technology transfer).
The National Innovation Agency (NIA) under the Ministry of
Science and Technology can also offer financial support
and technical services for innovators seeking marketing
assistance. NIA can award soft loans of up to US$125,000
for marketing and feasibility studies. In addition, NIA canalso enter into joint ventures (with less than 25% equity)
with companies and other investment organizations if such
arrangement can result in significant innovation.
Moving Forward
Thailand will continue to establish itself as a major
biotechnology player in the region. With a clear focus that
leverages upon the nation's advantages, Thailand willconcentrate its efforts on key areas of biotechnology R&D.
It will also continue to enhance its supporting infrastructure
and boost the quality and quantity of its human resource.
The establishment of the 40,000 sqm BioPark by 2009
which will accommodate Agro-business, life sciences
research, an incubation center and a pilot plant, will
enhance the country's competitiveness in the bioIndustry.
Thailand's new Suvarnabhumi International Airport, which
has the largest terminal building in the world (563,000
sqm) with a capacity to handle 45 million passengers and
3 million tonnes of cargo per year, will enhance the country's
global logistic network. Finally, the setting up of a
regional training center in biotechnology with the support
from UNESCO, FAO and the Rockefeller Foundation will
help develop strong research capabilities in the region to
meet future demand for qualified manpower from industry.
These and various developments are set to make Thailand
a preferred location for foreign Biobusiness in Asia.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
12/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 23
Forms of Doing Business
Types of Companies
A Thai or foreigner may engage in business in the form of
a partnership, limited company, a joint venture, a branch of
a foreign corporation, or a representative/regional office.
Partnerships
There are 3 types of partnerships and they differ principally
in the liability attached to each:
An unregistered ordinary partnership has partners who
are all jointly liable, without any limitation on the
partnership's total obligations. This type of partnershipis not a legal entity and is subject to taxation as if it
were an individual.
While there are many advantages to using the ordinary
partnership business organization, its use by foreigners is
limited by the Foreign Business Act (FBA), if it engages in a
business that is restricted under the FBA. An ordinary
partnership owned by Americans may apply for treaty
protection under the Treaty of Amity and Economic Relations. A registered ordinary partnership is a juridical entity
having a separate and distinct personality from each
of the partners by virtue of its registration with the
Commercial Registrar. It is treated as a corporate
entity for income tax purposes.
Generally, the registered ordinary partnership form of business
organization is not very popular, since it offers little or no apparent
tax advantages and little or no protection against liability.
A limited partnership is a form of registered partnership,
in which there are one or more managing partners who
manage the business and who are personally liable forthe partnership's debts, and one or more partners who
are not normally personally liable for the partnership's
debts, except for their undelivered or withdrawn capital
contributions. The partnership agreement, including the
details of capital contribution, management and objects,
must be filed with the Ministry of Commerce, in the
same manner as a registered ordinary partnership.
Limited partnerships are a popular form of business
organization, since they provide an aspect of limited liability
with fewer formalities than are required of limited companies.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
13/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 724
Private Limited Companies
The private company is the form of business organization that
is most popular with foreign businessmen, because there is
flexibility, especially in joint venture situations, in formulating
how the company may be controlled and managed. Thecompany may be wholly owned by foreigners. However, in
those business activities reserved for Thai nationals, foreign
participation is generally allowed up to 49%.
The liability of the shareholders is limited to the par value
of the authorized capital. The liability of the directors,
however, may be unlimited if so provided in the company's
memorandum of association or the articles of incorporation.
The limited company is managed by a board of directorsaccording to the company's memorandum and by laws.
Although there is no established minimum level of
capitalization, the private limited company's capital must be
sufficient to accomplish its objectives. All of the shares
must be subscribed to, and at least 25% of the subscribed
shares must be paid up.
Thai corporate law has some features, which may be
unfamiliar to foreign businessman. Limited companies are
subject to corporate income tax at the general rate of 30%.
Private limited company's shareholders must never be fewer
than seven at all times.
Joint Ventures
The term "joint venture" refers to unregistered partnership,
in which at least one of the partners is a juristic person and
which carries on business whereby the parties maintain
joint accounts and share profits. A significant aspect of a
joint venture is that it is taxed as a juristic person at the
general rate of 30%.
Consortiums
A consortium is similar to a joint venture, in that the parties
to a limited degree act together in a business enterprise.
However, unlike a joint venture, they maintain separate
accounts and do not share profits. A consortium does not
pay income tax as such, but the parties to the consortium
pay their own taxes.
Branch offices
A foreign juristic person may do business in Thailand by
establishing a branch office and also complying with any
relevant laws relating to its business. If the branch office
intends to engage in a business that is restricted under the
Foreign Business Act, then it must apply for a license.
If the company establishing a branch is an American
company and can comply with the provisions of the Treaty
of Amity and Economic Relations, the branch office may
apply for a treaty protection letter from the Ministry of
Commerce and thereafter engage in any business, except
those excluded by the treaty. If the treaty is applicable, the
American company must apply for a certificate, but need
not apply for a license under the Foreign Business Act.
Since a branch office is for legal purposes a part of theparent company, the parent is liable under civil and criminal
law for all the acts and omissions of the branch office.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
14/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 25
Representative office
A representative office may be established by a foreign
company. Normally, a representative office is limited to acting
as a buying office, carrying out market research and engaging
in quality control. It may not engage in trading activities inThailand. Representative offices require a license under the
Foreign Business Act, since they are regarded as service
businesses under Schedule 3 of the Act.
A representative office is normally required to remit into
Thailand for its operating expenditure, a total of Baht 5
million over a period of five years, with Baht 2 million being
remitted within the first year. These funds may not later be
remitted out. The capital may be used for normal workingcapital requirements, e.g. to pay operating expenditure such
as salaries and office rent.
Regional offices
The government promotes Regional Offices in a manner
similar to Representative Offices. Regional Offices supervise
and control their affiliates and subsidiaries in Thailand and
elsewhere in the region. They are not permitted to have
income but are reimbursed for expenditure.
International trade and support office
A foreign company may establish an International Trade
and Support office. Application is made to the Ministry of
Commerce under the provisions of Schedule 3 of the
Foreign Business Act. Such an office may only engage in
limited activities, to collect marketing and other information
and pass it to the parent company. It must not engage in
income generating activities.
The parent company must transfer into Thailand at least 5
million Baht as operating capital, of which at least 2 million
Baht must be transferred in the first year, and at least 1
million Baht per year after that.
Regional operating headquarters
Foreign companies can establish a regional operatingheadquarters in Thailand. Attractive tax incentives are
available to a regional operating headquarters.
Tax concessions are offered to regional operating
headquarters, for instance, 10% corporate tax will be charged,
instead of the usual rate of 30%, on: (1) on its general
income; (2) on net profits from royalties derived from
research and development in Thailand; and (3) on interest
from loans made to branches or subsidiaries.
Restricted business activities
The Foreign Business Act places restrictions on the
businesses that may be carried on by an Alien in Thailand.
The definition of Alien ncludes a company or partnership
which has at least half its shares owned by foreigners, a
foreign company or a foreign individual. Accordingly, a Thai
company which has only a minority of its shares owned byforeigners is not an Alien for the purposes of the Act. The
Act imposes restrictions on 43 categories of business
activity divided into three Schedules, Schedule 1, Schedule
2 and Schedule 3 (see below).
For businesses listed in Schedule 1, only minority
foreign ownership is permitted and there is no right
to apply for majority foreign ownership.
For businesses listed in Schedule 2, minority foreign
ownership is possible without permission. Up to 60%
(with a possibility of applying for up to 75%) foreign
ownership is possible with ministerial approval. At
least 40% of the directors must be Thai nationals.
For businesses listed under Schedule 3, minority foreign
ownership is possible without permission. Majority
foreign ownership is possible with permission of the
Commercial Registration Department and approval of
the Alien Business Board.
To obtain approval for majority foreign ownership of a Schedule
2 or 3 business, a foreign investor will have to demonstrate
that the nature of the business contributes to a number of
matters, including: national safety and security; economic and
social development; natural resources and energy conservation;
environmental protection and consumer protection. Other matters
that will be taken into account include: the size of the business;
the creation of employment, the transfer of technology, and
research and development.
The most significant achievement of the Act is that manufacturing
is now almost completely de-restricted, with the exception of a
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
15/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 726
small number of sensitive industries or products. However,
services are still generally restricted to minority foreign
ownership. In addition, the Act partially de-restricts certain
services, including; construction; trading; wholesaling;
distribution and retailing, subject to minimum investment
and other requirements.
As to any activity that is listed in the three Schedules,
provided foreign ownership is maintained at less than 50%,
then no license is required under the Act. If the particular
business activity is not restricted under any of the three
Schedules or under any other law, then there are no
limitations on foreign ownership.
The United States - Thailand Treaty of Amity. Under this Treaty, American and Thai citizens and corporations are
granted special preferential rights concerning the ownership of businesses in each others countries.
The foreign ownership restrictions discussed above are summarised in the table below:
The Australian-Thailand Free Trade Agreement (TAFTA) contains a section that also grants preferential rights to
Australian investors and companies in a number of different industries in Thailand, but subject to detailed conditions. Such
rights may be greater than the rights available under the Foreign Business Act or other applicable laws (see above).
Accordingly, when an Australian individual or company is considering setting up company in Thailand, it may be necessary to
refer to TAFTA, to ascertain whether Australian investors have any special rights to own such a business.
The enhanced rights of business ownership enjoyed by Australian investors with relevance to biotechnology sector
are summarised in the table below.
ExceptionsBusiness and
relevant law
Minority foreign
ownershipMajority foreign ownership
FBA Schedule 1businesses
FBA Schedule 2
Businesses
FBA Schedule 3
businesses
USA - Thailand
Treaty of Amity -
any businesses
No permissionrequired
No permission
required
No permission
required
No permission
required
Not possible
With permission of the Cabinet, up
to 60% and possibly up to 75%
but three fifths of directors must
be Thai.1
With permission of the Foreign
Business Registrar, up to 100%
foreign ownership no nationality
requirement for directors.2
No permission required
BOI may also grant
permission subject to 1
BOI may also grant
permission subject to 2
Businesses excluded from
the Treaty: exploitation of
land or natural resources,
domestic trade in indig-
enous agricultural products.
Nature of businessNew foreign ownership
limit under TAFTA
Previous foreign
ownership limit
Tertiary education institutions
specialising in science andtechnology
49% (a service business under
FBA Schedule 3)
60% but must be located outside
Bangkok
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
16/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 27
Promoted investment
The Government relies on a number of instruments to
support private business investment. Investment promotion
by the Board of Investment (BOI) is one such instrument.
The BOI operates in accordance with the powers contained inthe Investment Promotion Act 1977 in order to administer a
program of incentives for both Thai and foreign businessmen
who wish to establish or expand suitable businesses in
Thailand. In appropriate cases and in accordance with the
guidelines listed below, the BOI grants special privileges to
those who invest in approved projects. The BOIs current
policy is to promote life science business in Thailand through
the grant of special incentives and tax privileges.
Whilst the BOI provides valuable incentives, many Thai and
foreign businessmen establish businesses without BOI
assistance. Accordingly, investors should carefully consider
the pros and cons of seeking BOI incentives before making
an application. For instance, foreign investors often desire
to own all or at least a majority interest in their manufacturing
subsidiaries established abroad. Where such a subsidiary in
Thailand seeks BOI privileges, the BOI will allow it to be
majority or 100% foreign owned, subject to conditions.
The most important privileges available are summarized as
follows:
Permission for majority foreign ownership of a promoted
business which would otherwise be restricted under
Schedule 2 or 3 of the Foreign Business Act;
Permission for the enterprise to own land for use in
the promoted business;
Exemption from various taxes imposed on the business,
including exemption from the requirement to withhold
tax on dividends and royalty payments;
Permission to remit capital, profits, interest and principal
on foreign loans, royalties, fees or other obligations in
foreign currency;
Permission to employ foreign experts and technicians
on more advantageous terms than permitted by the
Ministry of Labour;
Exemption from import duties for machinery imported
for use in the business; Exemption from import duty, or reduction of duty
on raw or essential materials used in the business;
Exemption from corporate income tax for a period of 3,
5 or 8 fiscal years respectively in Zones 1, 2, and 3 (see
below), depending on the size of investment or number
of full time employees. An extended tax holiday may be
granted to businesses located in certain provinces in
Zone 3 for an additional 5 years, subject to furtherrequirements;
Dividends may be exempted from tax for a period
equal to the period of exemption from corporate
income tax;
Exemption from tax on payments of royalties and
fees for up to five years;
Zone 1: Bangkok, Samut Prakan, Samut Sakhon, Pathum
Thani, Nonthaburi and Nakhon Pathom
Zone 2: Samut Songkhram, Ratchaburi, Kanchanaburi,
Suphanburi, Ang Thong, Ayutthaya, Saraburi, Nakhon Nayok,
Chachoengsao, Chon Buri, Rayong and Phuket
Zone 3: The remaining 58 provinces.
All Zone 3 provinces are designated as Investment Promotion
Zones.
Laboratory accreditation
The Bureau of Laboratory Quality Standards serves as the
national accreditation agency to certify health products analysis
and clinical laboratories in accordance with ISO/IEC 17025.
Such certification is necessary for the laboratories to
perform laboratory services for the purpose of health product
registration with the Food and Drug Administration (FDA).
The Bureau also conducts proficiency testing and technical
consultancy and training services to clinical laboratories.
Permits for Doing Business
Factory establishment and operating licences
The Factory Act B.E. 2535 (1992) stipulates regulations for
factory construction and operation, factory expansion and
safety requirements. The Act is enforced by the Departmentof Industrial Works at the Ministry of Industry.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
17/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 728
A factory is defined as any premise, that uses machinery
equivalent to 5 horsepower or more, or that employs 7 or
more workers, with or without any machine, for manufacturing,
producing, assembling, packing, repairing, maintaining, testing,
improving, processing, conveying, storing or destroying
anything included in the classes or types of factories presently
listed in the ministerial regulations.
A factory may include a laboratory while workers may
include researchers.
Under the Factory Act B.E. 2535 (1992), factories are
separated into three groups according to the gravity of
impact of the factory operations to the public or the
environment, as follows:
Group 1 - Factories that can operate immediately
without prior government permission.
Group 2 - Factories that require prior notification of the
pertinent government authority before the business starts
operations. Group 3 - Factories that require the application for a
factory license before the establishment of the factory.
The Factories Act also regulates the standards and
procedures for control of waste, pollution and any activity
that may harm the environment as a result of business
operations, and necessary documentation and data which
must be kept by factories to ensure compliance with the
Act and its regulations. Violators of the Act are liable to fines
ranging from $8,000 to $16,000 and/or prison sentences.
An application to establish a factory must be submitted to
the Ministry of Industry in Bangkok, or if the factory is
outside Bangkok, it may be submitted to the provincialoffice. Full plans and details concerning the construction
and proposed purpose of the factory must be submitted.
Where required, an Environmental Impact Study must be
submitted as well and approved before a Factory Establishment
License may be granted.
After the construction of the factory, the manufacturer must
apply for a Factory Operating License. If on inspection it
appears that the factory and its machinery conform to theFactory Establishment License, a Factory Operating License
will be issued.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
18/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 29
Before the construction of a factory classified under Group 3,
the operator must obtain a factory license from the
Department of Industrial Works, Ministry of Industry. Application
for a license entails completing an official form, submitting
drawings and particulars of the factory, machinery, and
acceptable effluent treatment system, and attaching thedocuments stipulated on the form.
The operator of a Group 3 factory must notify the competent
authority at least 15 days before a factory test-run
commences, and again 15 days before actual manufacturing
operations start. The factory license is valid up to the last
day of the fifth calendar year from the year of commencement
and is renewable. An application for renewal of the factory
license must be filed prior to the expiration of that license.
Licensees must also obtain prior permission from the
Ministry of Industry for any factory expansion, transfer of
machinery to other sites, or transfer of factory site. Permission
is likewise required in order to transfer, lease, assign, or
sell a factory operation.
Import and export controls
There are regulations on the import and export of goods
into and out of Thailand. Trade in certain items is restricted
through outright prohibition, imposition of duties or licensing
requirements.
Import controls
The Ministry of Commerce designates classes of goods
that are subject to import controls, which usually take the
form of permission and licensing. Although these controls
are being liberalized, at present more than 50 classes of
goods require import licenses from the Ministry of Commerce.
These categories are frequently changed through notifications
from the ministry. A license to import any of the specified
items must be secured from the Ministry of Commerce. In
addition to the Act imposing the above controls, a
number of goods are subject to import controls under
other laws. With relevance to biotechnology, these include:
The import of modern drugs requires prior licensingfrom the Food and Drug Administration under the
Ministry of Health;
The Minerals Act stipulates that without appropriate
permission, an importer is prohibited from importing
tungsten oxide and tin ores and metallic tin in
quantities exceeding two kilograms;
The Cosmetic Act stipulates that for the purpose of
protection of public health, any importer of controlledcosmetics must provide the name and location of
the office and the place of manufacture or storage of
the cosmetics, the name category, or kind of
cosmetics to be imported, and the major components
of the cosmetics.
Biotech hardware and chemicals and live specimens for
research are regulated by the Thai Customs Department.
The taxes for biotech hardware and chemicals are 5 % ofthe total cost whereas those for live specimens are 10 %
of the total cost. Hazardous and exotic organisms are
quarantined by the Department of Medical Sciences,
Ministry of Public Health.
Export Controls
The Act Controlling the Importation and Exportation of Goods
authorizes the Ministry of Commerce to subject products to
export control. At present, close to 50 items require such
control. Certain goods require export licenses under other
laws, such as seeds, trees, and leaves of tobacco.
Import, export and possession of hazardous
substances in Thailand
The Act includes ten categories of hazardous chemicals as
follows:
Explosives
Flammable substance
Oxidizing agent and peroxide
Toxic substance
Substances causing diseases
Radioactive substance
Mutant causing substance
Corrosive substance
Irritating substance
Other substance either chemicals or otherwisewhich may cause injury to the persons, animals,
plants, property or environments.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
19/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 730
Hazardous substances are classified into four groups:
Category I hazardous chemicals for which the production,
import, export must be in compliance with the principles
and procedures promulgated. Category II hazardous chemicals
for which the production, import, export or being in
possession must be informed to the authorities. Category
III hazardous chemicals for which the production, import,
export or being in possession must be permitted. Category
IV hazardous chemicals for which the production, import,
export or their possession are legally forbidden.
No registration is necessary for chemicals of category I
while categories II and III need to be registered before
manufacture and/or import.
Importation, handling and disposal of radioactive
materials
The importation, handling and disposal of radioactive
materials is strictly regulated under the Atomic Energy for
Peace Act and radiation safety regulation. The Act and
regulations are enforced by the Office of Atomic Energy for
Peace of the Ministry of Science Technology and Environment
as well as the Department of Medical Science at the
Ministry of Public Health. The Office of Atomic Energy for
Peace looks after the utilization of radioactive materials and
other radiation sources, while the Department of MedicalScience looks after X-ray machines.
The Office of Atomic Energy for Peace is responsible for
licensing the utilization of radiation sources other than X-ray
machines. The responsibilities include authorization and
inspection, waste management and the information exchange.
Applications for importation, handling and disposal ofradioactive materials shall be submitted to Office of Atomic
Energy for Peace for approval according to sections 12 &
13 of the Atomic Energy for Peace Act B.E 2504.
Environmental legislation
The Enhancement and Conservat ion of National
Environmental Quality Act B.E. 2535 (A.D 1992) is the
most significant environmental legislation. The Act continuesand expands the responsibilit ies of the National
Environment Board (NEB) and created incentives for
environmental promotion and preservation, prescribes
penalties for polluters for the establishment of a fund for
promotion and preservation of environment quality and gives
the public a greater participation role in addressing
environmental problems.
The Act for the Cleanliness and Orderliness of the Country
B.E. 2535 (A.D. 1992) regulates and controls offences to
the environment deemed dangerous or unsightly. The Act
specifically prohibits the dumping of waste and waste
by-products into bodies of water.
Minister notifications and regulations issued under the
Factories Act B.E. 2512 (A.D. 1969) control the level of
effluent discharged by factories and restrict concentration
levels of chemical and/or metal pollutants to defined
parameters.
About the Author
Rouse & Co International provides a full range of intellectual
property services world-wide. We help manage patent
portfolios and advise on strategies that will enable the full
potential of the patents to be realized. Fabrice Mattei is a
partner and has been working in Thailand in the fields of
patent and biotechnology for the last 12 years.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
20/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 31
Human Resources
A key success factor for Thailand's biotech industry is the
development and management of its biotech human resources.
Many initiatives are now in place to grow the local talent pool.
Thai professionals abroad are encouraged to return home to
contribute towards the growth of the local biotech scene.
Specifically, the National Science and Technology Development
Agency (NSTDA) has initiated a "Reverse Brain Drain Project"
to encourage Thai professionals with backgrounds in science,
engineering or medicine to return to share their technical
skills with their fellow countrymen. More information on the
project can be found at the NSTDA's website at www.nstda.or.th/
rbd (note: the information is written in Thai). In addition,
universities across the nation are beginning to offer morerelevant courses and degrees in the areas of science and
engineering. Both private companies and the Thai government
are offering scholarships to increase accessibility of education
in this exciting area.
To succeed in Thailand, companies starting up should have
a good understanding of the legal framework surrounding
labour issues and an appreciation of Thailand's cultural
perspective. There should also be a thorough planningprocess to address common HR issues such as salaries
and benefits, employee relations, HR practices and termination
concerns prior to initiation of operation. Some of the
common employment laws and issues are detailed below:
Labour Laws
Designed to protect workers and preserve their rights, the
following legislations govern labour issues in Thailand: Labour Protection Act
Labour Relations Act
The Act Establishing the Labour Court and Labour
Court Procedure
Provident Fund Act
Social Security Act
Workmen's Compensation Act
Thai Civil and Commercial Code
The Labour Protection Act underlines the minimum
employment condition requirements for an employee in the
private sector, including minimum and maximum working
hours, holidays, minimum wages, child and woman labor,
leaves (sick, maternity, military and business) and severance
pay. The Labour Relations Act provides the guidelines for
the estab lishment of unions and the negot iation ofemployment contracts. The minimum age of employment
in Thailand is 15 years for standard jobs and 18 years for
dangerous or hazardous jobs.
Under the current labour laws, some of the benefits
that all employees are entitled to include:
13 national holidays per year.
1 day off per week (usually Sunday).
Minimum of 6 working days of annual paidvacation upon completion of 1 year of employment.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
21/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 732
Up to 30 days of paid sick leave.
90 days of maternity leave. Pregnant employees are prohibited from working overtime, on holidays, or
between 10 p.m. and 6 a.m.
Maximum of 48 and 42 work hours a week for non-hazardous and hazardous works respectively.
Paid overtime compensation for extra hours but limited to maximum of 36 hours a week.
1 hour of rest after every 5 consecutive hours of work or a total of 1 hour of rest per work day.
Access to welfare facilities at the workplace, including medical and sanitary facilities.
Severance pay entitlement for employees with minimum of 120 days of service. Pay amount is dependent on
duration of service.
Duration of service Severance pay amount
120 days to less than 1 year 30 days of wage
1 - 3 years 90 days of wage
3 - 6 years 6 months wage
6 - 10 years 8 months of wage
> 10 years 10 months of wage
There is an on-going effort to translate the various Acts of Parliament from Thai into English. Translated versions of
some of these Acts can currently be found at the Thai Law Reform Commission (TLRC) website at www.lawreform.go.th
or the website of the Office of the Council of State at www.krisdika.go.th.
Guidelines on the criteria and rate of compensation benefits payment are stipulated in the Act. The general provisions
are as follow:
Category Range of Compensation Benefits
Cash compensation 2,000 to 9,000 baht
Medical expenses Up to 35,000 baht for normal case
Up to 50,000 baht for serious injury
Work rehabilitation expenses Up to 20,000 baht
Funeral expenses Up to 100 times of minimum daily wage rate
Workmen's Compensation Fund
In accordance with the Workmen's Compensation Act,
employers in Thailand are required to make annual
contributions to the Workmen's Compensation Fund.
The contribution rate varies from 0.2 1% of the employees'
annual wages and is dependent on the categorized risk rating
of the company and the companies prior work related
accident record. This fund is used to provide compensation
benefits to employees or their next-of-kins for injuries,
illnesses or deaths resulted from work related accidents.
Compensation benefits are categorized into 4 groups:
Cash compensation
Medical expenses
Work rehabilitation expenses
Funeral expenses
More details on the Workmen's Compensation Fund and
the various benefit entitlements may be found at the Social
Security Office website at www.sso.go.th/eng/index_en.html.
Minimum wages
Different minimum wages are applicable to businesses
located in the different provinces. The minimum wage per
day (effective January 1, 2006) ranges from 140 Baht in
the northern provinces of Phayao and Phrae to 184 Baht in
the capital, Bangkok.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
22/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 33
Social Security Fund
The Social Security Act provides for the creation of the
Social Security Fund, which provides benefits to the
employee and his dependents for loss of work due to
non-work related injury, illness, maternity, disability, death,
or retirement. The fund is financed through monthly
contributions by the employers and employees (including
foreigners). Currently, each party contributes 4.5% of the
employee's monthly wage to the fund, up to a monthly
wage ceiling of 15,000 Baht. More details on the Social
Security Fund and the various benefit entitlements may be
found at the Social Security Office website at www.sso.go.th/
eng/index_en.html.
Provident Fund
Under the Labour Protection Act, employers with 10 or
more employees, and their employees, are required to
contribute to an employee welfare fund. This fund will be
used for lump sum or periodical payments to workers who
resign or are laid off. It also serves as compensation to the
dependents of employees who died in service.
Hiring Foreigners
Foreigners may not work in a number of occupations, including
the following, which are related to the biotechnology industry:
Agriculture, animal husbandry, forestry, fisheries, except
for work requiring special expertise, farm supervision
or labour in fisheries especially marine fisheries
Engineering in civil engineering concerning design and
calculation systemization analysis, planning, testing,construction supervision or consulting services,
excluding work requiring specialized techniques
Work Permit
A foreigner who intends to work in Thailand will need to first
obtain a non-immigrant visa (usually business - category B)
to enter the country. Such a visa will entitle the holder to stay
in Thailand for a maximum period of 90 days. Non-immigrantvisas may be obtained from a Royal Thai embassy or
consulate by producing several documents, including an
employment letter from a company registered in Thailand. More
information on the visa application process may be found at the
Thai Ministry of Foreign Affairs' website at www.mfa.go.th.
With the aim of facilitating employment and immigration needs
of foreign investors, the Thailand's Board of Investmentestablished a One-Stop Service Center jointly with the Immigration
Bureau and the Department of Employment. The Center is
tasked to provide quick turnaround for visas and work permits
applications and renewals, usually within 3 hours upon receipt
of the complete and accurate documentations. In addition, the
center handles other transactions such as the issuance of multiple
re-entry stamps, changes in visa class and payment of fines.
It should be noted that the services offered by the One StopService Center are only available to foreign investors, experts
and executives who have met certain criteria. Investors are
advised to contact the One Service Center for additional
information to see if they qualify for the Center's services.
The Center's contact info is as follow:
One Stop Service Center for Visas and Work Permits Office
of the Board of Investment
207 Glas Haus Building Ratchada, 3rd floor, Ratchadapisek
Road Din Daeng, Din Daeng, Bangkok 10400
Tel: 0-2693-9333-38 Fax: 0-2693-9352
E-mail: [email protected]
The following sections have been extracted from the
website of the Board of Investment
http://www.boi.go.th./english/how/labor_issues_and_
important_addresses.asp
Legal Implications of LabourManagement
Thai labour laws provide for considerable freedom in
managing labour. As in many countries, it is not legal to
discriminate on the basis of age or sex. However, personnel
ads in Thai newspapers show employers narrowly defining
their needs: "The successful candidate will be male, under35 years of age, not a member of a labour union, and at
least 150 cm in height, etc."
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
23/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 734
Furthermore, the government does not interfere with a
company's retrenchment policies when economic condi-
tions necessitate cutbacks. There is no "first in, last out"
requirement in Thailand.
Similarly, Thai employers have the right to transferemployees to other work locations, provided the transfer is
not ordered with the exclusive intent to create hardship for
them. Refusal to transfer is legal cause for dismissal.
Employee records
An employer with 10 or more regular employees is
required to establish written rules and regulations in Thai
governing work performance. The regulations must bedisplayed at the work premises within 15 days of the date
from which the number of employees reached 10 or more.
An employer with 10 or more regular employees is also
required to maintain an employee register in Thai with
documents pertaining to the payment of wages, overtime,
holiday work etc.
Tips on Recruiting and Developing Staff
The ability of a company to attract and retain staff is
enhanced by tailoring compensation packages to meet the
needs of individual employees. Increasingly, factors such as
work environment, organizational policies, relationships with
superiors, and defined career path influence decisions whether
to join or remain with a company. In a challenging living
environment such as Bangkok, these "quality of life"
factors are important.
Organizing training programs to upgrade skills helps to
motivate staff and demonstrates a company's commitment
to its employees. Admission to such programs can be seen
both as a reward for good performance and as part of the
total compensation package.
Recruiting Technically-skilled Manpower
There are two main English language daily newspapers
which support advertisements, both in English and in Thai.
Both the Bangkok Post and The Nation boast circulation
figures of close to 60,000 copies per day, and their
advertising rates are similar. In addition to these
mass-market dailies, there is an English-language daily, the
Business Day, which claims a daily circulation of
approximately 10,000. Prospective employees can be reachedthrough the print editions of these newspapers as well as
online classified advertisements on their websites.
The Department of Employment, Ministry of Labor and
Social Welfare also has a website which list job fairs and
employment opportunities. It is found at http://www.doe.go.th/
eng/index/html.
Several domestic and international personnel recruitmentfirms operate in Bangkok. These companies also offer
services such as advice on issues of organizational
structure, labour relations, and the cultural implications of
managing labour in Thailand.
It is also recommended that companies develop contacts
with educational institutes to identify and court potential
candidates as early as possible. For companies with
ongoing manpower needs, establishing a network of
contacts can be especially valuable.
Besides tailoring compensation packages to individual needs
and emphasizing long-term and organizational benefits,
companies need to give high-end technical employees, such
scientists and engineers, work that are commensurate with
their skills. Given greater challenges and expanded roles in
areas like systems design and management, technical
personnel can become more productive and are more likely
to view themselves as an integral part of the company.
Concrete, long-term benefits are an effective retention tool.
Long-term benefits motivate personnel to work through
problems and to identify self-interest with company
interest. Committing resources to long-term benefits also
ensures that companies are able to realize increased
production levels from staff as they gain experience.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
24/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 35
Withholding Tax
Certain types of income paid to companies are subject to
withholding tax at source. The withholding tax rates depend
on the types of income and the tax status of the recipient.
The following table shows some of the prevailing withholding
tax rates:
Types of income Withholding tax rate
1. Dividends 10 %
2. Interest 10 % if paid to associations
or foundations
15 % in other case
3. Royalties 10 % if paid to associations
or foundations 3 % in other case4. Advertising Fees 2 %
5. Service and 3 % if paid to Thai company
professional fees or foreign company having
permanent branch in Thailand
5% if paid to foreign company
not having permanent branch
in Thailand
6. Prizes 5 %
It should be noted that government agencies are required
to withhold tax at the rate of 1% on all types of income
paid to companies.
The payer of income is required to file the return and
submit the amount of tax withheld to the District Revenue
Offices within seven days of the following month in which
the payment is made. The tax withheld will be credited
against final tax liability of the taxpayer.
Details of tax regime can be found at the Thai Revenue
Department website at www.rd.go.th. The website provides
comprehensive coverage on tax matters and is a valuable
online resource. Some of the more relevant sections are
summarized below:
Corporate Income Tax
Generally, companies are taxed on net profit derived from
business in Thailand at 30%. Various rate reductions are
available depending on the category of the company.
Personal Income Tax
Foreigners are considered Thai tax residents if they spend
180 days or more in Thailand during the calendar or tax
year. A tax resident is liable to pay tax on income from
sources in Thailand on a cash basis, regardless of where
the money is paid, as well as on the portion of income
from foreign sources that is brought into Thailand. Tax
rates for residents depend on their total taxable income
during the calendar year and range from 0% to 37%.
A non-resident is, however, subject to tax only on incomefrom sources in Thailand.
Value Added Tax (VAT)
The Value Added Tax (VAT) was implemented in Thailand
in 1992 as an indirect tax imposed on the value added of
each stage of production and distribution. Any person or
entity that regularly supplies goods or provides services in
Thailand and has an annual turnover exceeding 1.2 millionBaht is subject to the VAT. The current VAT is set at 7%.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
25/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 7 37
An Overview of Bio-IP Legal Frameworkin Thailand
In order to create a supportive infrastructure for biotechnology
industry development, the Thai Government has been
actively seeking to improve the laws governing the industry.
In particular, it is upgrading laws to provide a more favourable
environment for the protection and enforcement of
intellectual property, a vital element for the growth of
biotechnology.
There are five forms of intellectual property protection
relevant to the biotech industry, namely, patents, trade
secrets, plant variety, trademarks and copyrights.
However, the most used and relevant protection for thebiotechnology industry is patent.
Patents, utility models and designs1
Patent for invention
Having an appropriate patent portfolio helps attract
investment and assures investors that when products and
services are finally marketed, exclusivity will be assured to
the company. A patent gives the patentee exclusive rights,
empowering him/her to prevent another from using,
making, selling or offering for sale, importing or exporting
the invention claimed in a patent. The right is territorial and
limited to the country where the patent is granted.
Biotechnological inventions are generally protected through
patents, which can include composition of matter claims
for instance on isolated nucleotide or amino acid sequences.
It is not permissible to claim methods of medical treatment
of humans and animals, or methods of diagnosis in relation
to humans or animals. However, a method for preventing a
disease can be patented.
The Patent Act does not allow for patents on plants and
animals. Patents on micro-organisms are only granted ifthe organisms are modified. It further excludes patents on
plant varieties, which are protected under the Plant Variety
Protection. The law protects pharmaceutical products through
patent. Methods for the production of transgenic animals,
plants and micro organisms can also be patented as can
the organisms themselves as long as a discernable new
function or trait can be documented. For example, modified
Bt gene, isolated strains, purified strains etc.
What is the test for an invention to be capable of
patent protection? Are there separate tests for
biotechnology, medical device inventions?
The answer is no, the test is uniform. In order to obtain a
valid patent in Thailand, the subject invention must be
novel (that is, not known) and inventive at the date of filing
the patent application. A further requirement for a valid
patent is that the invention must be capable of industrial
application or be useful.
1Patent Act B.E. 2522 as amended by the Patent Act (No.2) B.E 2535 and the Patent Act (No.3) B.E. 2542.
-
7/31/2019 D517A Thailand Biotech Guide 2006-2007
26/56
T H A I L A N D B I O T E C H G U I D E 2 0 0 6 / 2 0 0 738
The novelty requirement can be troublesome. The invention
must not have existed somewhere (in or outside of
Thailand) in the form in which it is claimed. In the context
of biotechnology, the most obvious concern is the
patentability of natural products, which, at first glance,
appear to have pre-existed. However, if these materials canbe claimed in a manner, which distinguishes them from
their status as they occur in nature, there is no barrier to
patentability in properly constructed claims. For instance,
patents have been issued on DNA encoding erythropoietin,
pure TPA, DNA encoding TPA, and so forth.
The exclusive rights to the patentee are:
in the case of product patent, the right tomanufacture, use, sell, possess for sale, offer for
sale or import the patented products;
in the case of a process patent, the right to use the
patented process, manufacture, use, sell, possess
for sale, offer for sale or im